Approvals/CIMA-AEMPS/ANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)

Approved

STANDARD

ANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)

Glaxosmithkline Trading Services Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: ba83172d1e9125d9
Drug Cima Aemps Name: ANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)
Register Number: 114898002IP4
Holder Company Name: Glaxosmithkline Trading Services Limited
Marketing Company Name: Melyfarma S.L.
Holder Company Detail Path: /organization/glaxosmithkline-trading-services-limited
Authorization Date: 2025-09-15
Dosage Form: POLVO PARA INHALACIÓN (UNIDOSIS)
Dose: 55 MICROGRAMOS/22 MICROGRAMOS
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline Trading Services Limited
Company Detail Path: /organization/glaxosmithkline-trading-services-limited

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 15, 2025

Approval ID

ba83172d1e9125d9

Type

Standard